Xilio Therapeutics, Inc.XLONASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank0
3Y CAGR-45.0%
5Y CAGR-26.3%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-45.0%/yr
Annual compound
5Y CAGR
-26.3%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20250.14-54.8%
20240.32-64.9%
20230.90+4.6%
20220.86-19.4%
20211.07+63.0%
20200.65-36.6%
20191.03-